Literature DB >> 11226381

Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.

M Mishra1, J R Bennett, G Chaudhuri.   

Abstract

Ribonuclease H (RNase H), an enzyme that cleaves an RNA sequence base-paired with a complementary DNA sequence, is proposed to be the mediator of antisense phosphorothioate oligonucleotide (S-oligo) lethality in a cell. To understand the role of RNase H in the killing of the parasitic protozoan Leishmania by antisense S-oligos, we expressed an episomal copy of the Trypanosoma brucei RNase H1 gene inside L. amazonensis promastigotes and amastigotes that constitutively express firefly luciferase. Our hypothesis was that S-oligo-directed degradation of target mRNA is facilitated in a cell that has higher RNase H activity. Increased inhibition of luciferase mRNA expression by anti-luciferase S-oligo and by anti-miniexon S-oligo in these stably transfected promastigotes overexpressing RNase H1 was correlated to the higher activity of RNase H in these cells. The efficiency of killing of the RNase H overexpressing amastigotes inside L. amazonensis-infected macrophages by anti-miniexon S-oligo was higher than in the control cells. Thus, RNase H appears to play an important role in the antisense S-oligo-mediated killing of Leishmania. Chemical modification of S-oligos that stimulate RNase H and/or co-treatment of cells with an activator of RNase H may be useful for developing an antisense approach against leishmaniasis. The transgenic Leishmania cells overexpressing RNase H should be a good model system for the antisense-mediated gene expression ablation studies in these parasites.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11226381      PMCID: PMC3088082          DOI: 10.1016/s0006-2952(00)00568-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  44 in total

Review 1.  Morpholino antisense oligomers: the case for an RNase H-independent structural type.

Authors:  J Summerton
Journal:  Biochim Biophys Acta       Date:  1999-12-10

2.  Transcription of the Leishmania major Hsp70-I gene locus does not proceed through the noncoding region.

Authors:  A Dresel; J Clos
Journal:  Exp Parasitol       Date:  1997-07       Impact factor: 2.011

3.  Transcriptional mapping of the amplified region encoding the dihydrofolate reductase-thymidylate synthase of Leishmania major reveals a high density of transcripts, including overlapping and antisense RNAs.

Authors:  G M Kapler; S M Beverley
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

4.  Receptor-mediated drug delivery to macrophages in chemotherapy of leishmaniasis.

Authors:  A Mukhopadhyay; G Chaudhuri; S K Arora; S Sehgal; S K Basu
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Ribonuclease H. An enzyme degrading the RNA moiety of DNA-RNA hybrids.

Authors:  P Hausen; H Stein
Journal:  Eur J Biochem       Date:  1970-06

6.  Renaturase and ribonuclease H: a novel mechanism that influences transcript displacement by RNA polymerase II in vitro.

Authors:  C M Kane
Journal:  Biochemistry       Date:  1988-05-03       Impact factor: 3.162

7.  Molecular cloning and expression of cDNA for human RNase H.

Authors:  H Wu; W F Lima; S T Crooke
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1998-02

8.  Surface acid proteinase (gp63) of Leishmania mexicana. A metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages.

Authors:  G Chaudhuri; M Chaudhuri; A Pan; K P Chang
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

9.  Cloning of the cDNA encoding the large subunit of human RNase HI, a homologue of the prokaryotic RNase HII.

Authors:  P Frank; C Braunshofer-Reiter; U Wintersberger; R Grimm; W Büsen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

10.  Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani.

Authors:  Y Saar; A Ransford; E Waldman; S Mazareb; S Amin-Spector; J Plumblee; S J Turco; D Zilberstein
Journal:  Mol Biochem Parasitol       Date:  1998-09-01       Impact factor: 1.759

View more
  3 in total

1.  Molecular characterization of a human BRCA2 homolog in Leishmania donovani.

Authors:  Smita Misra; Mack Hall; Gautam Chaudhuri
Journal:  J Parasitol       Date:  2005-12       Impact factor: 1.276

2.  A type II ribonuclease H from Leishmania mitochondria: an enzyme essential for the growth of the parasite.

Authors:  Smita Misra; Jabbar Bennett; Yeshitila N Friew; Junaid Abdulghani; Charletha V Irvin-Wilson; Manish K Tripathi; Shauntae Williams; Minu Chaudhuri; Gautam Chaudhuri
Journal:  Mol Biochem Parasitol       Date:  2005-10       Impact factor: 1.759

3.  Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs.

Authors:  Jun-ichiro Suzuki; Naoko Miyano-Kurosaki; Tomoyuki Kuwasaki; Hiroaki Takeuchi; Gota Kawai; Hiroshi Takaku
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.